0002-7772-11 : NDC 2026 Code

0002-7772-11 : Lebrikizumab-lbkz ( Ebglyss )

Additionally :

You can get information about “0002-7772-11” NDC code in 0002-7772-11 in HTML format

HTML | 0002-7772-11 in TXT (Plain Text) format

TXT | 0002-7772-11 in PDF (Portable Document Format)

PDF | 0002-7772-11 in XML format

XML formats.

NDC Code : 0002-7772-11 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "0002-7772-11",
    "PackageDescription": "1 SYRINGE in 1 CARTON (0002-7772-11)  / 2 mL in 1 SYRINGE (0002-7772-01) ",
    "NDC11Code": "00002-7772-11",
    "ProductNDC": "0002-7772",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Ebglyss",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lebrikizumab-lbkz",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20240913",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761306",
    "LabelerName": "Eli Lilly and Company",
    "SubstanceName": "LEBRIKIZUMAB",
    "StrengthNumber": "250",
    "StrengthUnit": "mg/2mL",
    "Pharm_Classes": "Interleukin-13 Antagonist [EPC], Interleukin-13 Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20240913",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}